{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:23:40Z","timestamp":1787599420926,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003852","name":"Campania Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113137","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T23:22:02Z","timestamp":1653348122000},"page":"113137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines"],"prefix":"10.1016","volume":"151","author":[{"given":"Elisabetta","family":"Panza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Smimmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Brancaleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mitidieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"d\u2032Emmanuele di Villa Bianca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2022.113137_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/medsci8010015","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med. Sci."},{"key":"10.1016\/j.biopha.2022.113137_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0140-6736(09)60491-8","article-title":"Bladder cancer","volume":"374","author":"Kaufman","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113137_bib3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.7150\/jca.23162","article-title":"A real-world data study to evaluate treatment patterns, clinical characteristics and survival outcomes for first- and second-line treatment in locally advanced and metastatic urothelial cancer patients in Germany","volume":"9","author":"Niegisch","year":"2018","journal-title":"J. Cancer"},{"key":"10.1016\/j.biopha.2022.113137_bib4","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(20)30230-0","article-title":"IMvigor130 Study Group, Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"395","author":"Galsky","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2022.113137_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa2002788","article-title":"Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma","volume":"383","author":"Powles","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2022.113137_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.niox.2015.08.004","article-title":"Hydrogen sulfide in cancer: Friend or foe?","volume":"50","author":"Wu","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.biopha.2022.113137_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bcp.2018.01.042","article-title":"The dichotomous role of H2S in cancer cell biology? D\u00e9j\u00e0 vu all over again","volume":"149","author":"Kashfi","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113137_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7150\/ijbs.47850","article-title":"Role of hydrogen sulfide donors in cancer development and progression","volume":"17","author":"Ngowi","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biopha.2022.113137_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-3-319-18144-8_12","article-title":"Hydrogen sulfide and cancer","volume":"230","author":"Hellmich","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113137_bib10","doi-asserted-by":"crossref","first-page":"12474","DOI":"10.1073\/pnas.1306241110","article-title":"Tumor-derived hydrogen sulfide, produced by cystathionine-\u03b2-synthase, stimulates bioenergetics, cell proliferation, and angiogenesis in colon cancer","volume":"110","author":"Szabo","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113137_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2015.05.024","article-title":"Role of cystathionine \u03b2-synthase in human breast Cancer","volume":"86","author":"Sen","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2022.113137_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079167","article-title":"Cystathionine beta-synthase (CBS) contributes to advanced ovarian cancer progression and drug resistance","volume":"8","author":"Bhattacharyya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113137_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/s12885-018-4508-1","article-title":"Endogenous H2S producing enzymes are involved in apoptosis induction in clear cell renal cell carcinoma","volume":"18","author":"Breza","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2022.113137_bib14","first-page":"1818","article-title":"Expression of hydrogen sulfide synthases and Hh signaling pathway components correlate with the clinicopathological characteristics of papillary thyroid cancer patients","volume":"11","author":"Xu","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.biopha.2022.113137_bib15","doi-asserted-by":"crossref","first-page":"4145","DOI":"10.1096\/fj.201701095R","article-title":"Cystathionine \u03b2-synthase regulates mitochondrial morphogenesis in ovarian cancer","volume":"32","author":"Chakraborty","year":"2018","journal-title":"FASEB J."},{"key":"10.1016\/j.biopha.2022.113137_bib16","first-page":"473","article-title":"Cystathionine\u2011\u03b3\u2011lyase promotes the metastasis of breast cancer via the VEGF signaling pathway","volume":"55","author":"Wang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2022.113137_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/pcmr.12312","article-title":"Role of the cystathionine \u03b3 lyase\/hydrogen sulfide pathway in human melanoma progression","volume":"28","author":"Panza","year":"2015","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.biopha.2022.113137_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","article-title":"Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.biopha.2022.113137_bib19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/path.5266","article-title":"TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2\u03b1 as a therapeutic target","volume":"248","author":"Chen","year":"2019","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2022.113137_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s10753-017-0526-4","article-title":"Diallyl disulfide suppresses the inflammation and apoptosis resistance induced by DCA through ROS and the NF-\u03baB signaling pathway in human barrett\u2019s epithelial cells","volume":"40","author":"Feng","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.biopha.2022.113137_bib21","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/ijo.2014.2305","article-title":"GYY4137, a hydrogen sulfide (H\u2082S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway","volume":"44","author":"Lu","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.biopha.2022.113137_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/jf203800d","article-title":"Effect of diallyl sulfide on in vitro and in vivo Nrf2-mediated pulmonic antioxidant enzyme expression via activation ERK\/p38 signaling pathway","volume":"60","author":"Ho","year":"2012","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2022.113137_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.biochi.2015.03.009","article-title":"Hydrogen sulphide induces HIF-1\u03b1 and Nrf2 in THP-1 macrophages","volume":"112","author":"Lohninger","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.biopha.2022.113137_bib24","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.3892\/or.2016.4722","article-title":"Diallyl trisulfide induces osteosarcoma cell apoptosis through reactive oxygen species-mediated downregulation of the PI3K\/Akt pathway","volume":"35","author":"Wang","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113137_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2017.00065","article-title":"The hydrogen sulfide releasing molecule acetyl deacylasadisulfide inhibits metastatic melanoma","volume":"8","author":"De Cicco","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113137_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24142665","article-title":"Diallyl disulfide induces apoptosis and autophagy in human osteosarcoma MG-63 cells through the PI3K\/Akt\/mTOR pathway","volume":"24","author":"Yue","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2022.113137_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s42826-019-0030-0","article-title":"Inhibition of STAT3 signaling induces apoptosis and suppresses growth of lung cancer: good and bad","volume":"35","author":"Kang","year":"2019","journal-title":"Lab Anim. Res."},{"issue":"4","key":"10.1016\/j.biopha.2022.113137_bib28","first-page":"248","article-title":"NF-\u03baB and MAPKs are involved in resistin-caused ADAMTS-5 induction in human chondrocytes","volume":"38","author":"Omer Faruk Hatipoglu","year":"2015","journal-title":"Clin. Investig. Med."},{"key":"10.1016\/j.biopha.2022.113137_bib29","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1016\/j.bmcl.2012.02.102","article-title":"Sinularioside, a triacetylated glycolipid from the Indonesian soft coral Sinularia sp., is an inhibitor of NO release","volume":"22","author":"Putra","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.biopha.2022.113137_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197815","article-title":"Integration of in vitro and in silico perspectives to explain chemical characterization, biological potential and anticancer effects of Hypericum salsugineum: a pharmacologically active source for functional drug formulations","volume":"13","author":"Bender","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113137_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.350","article-title":"Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment","volume":"4","author":"Sui","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2022.113137_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2022.113137_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1349-7006.2009.01419.x","article-title":"Epithelial-mesenchymal transition in cancer development and its clinical significance","volume":"101","author":"Iwatsuki","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2022.113137_bib34","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biopha.2022.113137_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2019.04.031","article-title":"A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K\/AKT\/mTOR and Ras\/Raf\/MEK\/ERK signaling pathways","volume":"455","author":"Dong","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2022.113137_bib36","article-title":"The slow-releasing hydrogen sulfide donor, GYY4137, exhibits novel anti-cancer effects in vitro and in vivo","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2022.113137_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e02244","article-title":"Hydrogen sulfide donor GYY4137 suppresses proliferation of human colorectal cancer Caco-2 cells by inducing both cell cycle arrest and cell death","volume":"5","author":"Sakuma","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.biopha.2022.113137_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bcp.2017.10.011","article-title":"Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation","volume":"149","author":"Ol\u00e1h","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113137_bib39","first-page":"6562","article-title":"Exogenous hydrogen sulfide promotes hepatocellular carcinoma cell growth by activating the STAT3-COX-2 signaling pathway","volume":"15","author":"Zhen","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.113137_bib40","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.3892\/or.2016.4734","article-title":"Exogenous hydrogen sulfide exerts proliferation, anti-apoptosis, angiopoiesis and migration effects via activating HSP90 pathway in EC109 cells","volume":"35","author":"Lei","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113137_bib41","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2022.113137_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2015.06.020","article-title":"Expression profile of hydrogen sulfide and its synthases correlates with tumor stage and grade in urothelial cell carcinoma of bladder","volume":"34","author":"Gai","year":"2016","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.biopha.2022.113137_bib43","first-page":"8484","article-title":"Increased H2S and its synthases in urothelial cell carcinoma of the bladder, and enhanced cisplatin-induced apoptosis following H2S inhibition in EJ cells","volume":"15","author":"Wahafu","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.biopha.2022.113137_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.phrs.2016.10.019","article-title":"ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo","volume":"114","author":"De Cicco","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2022.113137_bib45","doi-asserted-by":"crossref","first-page":"17977","DOI":"10.1073\/pnas.0705710104","article-title":"Hydrogen sulfide mediates the vasoactivity of garlic","volume":"104","author":"Benavides","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biopha.2022.113137_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb05594.x","article-title":"Programmed cell death (PCD). Apoptosis, autophagic PCD, or others?","volume":"926","author":"Bursch","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2022.113137_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4062\/biomolther.2015.013","article-title":"Cancer metabolism: strategic diversion from targeting cancer drivers to targeting cancer suppliers","volume":"23","author":"Kim","year":"2015","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.biopha.2022.113137_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109490","article-title":"Inhibition of autophagy enhances the anticancer effect of enzalutamide on bladder cancer","volume":"120","author":"Quan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2022.113137_bib49","doi-asserted-by":"crossref","first-page":"1801927","DOI":"10.1002\/advs.201801927","article-title":"ATG7 promotes bladder cancer invasion via autophagy-mediated increased ARHGDIB mRNA stability","volume":"6","author":"Zhu","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biopha.2022.113137_bib50","first-page":"220","article-title":"Autophagy is a therapeutic target in anticancer drug resistance","volume":"2010","author":"Chen","year":"1806","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2022.113137_bib51","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/15548627.2015.1017182","article-title":", PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells","volume":"11","author":"Rah","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2022.113137_bib52","first-page":"117","article-title":"Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies","volume":"3","author":"Talbot","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2022.113137_bib53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.devcel.2008.05.009","article-title":"Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis","volume":"14","author":"Yang","year":"2008","journal-title":"Dev. Cell"},{"key":"10.1016\/j.biopha.2022.113137_bib54","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/1541-7786.MCR-11-0271","article-title":"IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway","volume":"9","author":"Yadav","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.biopha.2022.113137_bib55","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/1878-0261.12017","article-title":"Epithelial-mesenchymal transition in tumor metastasis","volume":"11","author":"Yeung","year":"2017","journal-title":"Mol. Oncol."}],"updated-by":[{"DOI":"10.1016\/j.biopha.2026.119135","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000}},{"DOI":"10.1016\/j.biopha.2026.119135","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000}}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222005261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:52:09Z","timestamp":1787597529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222005261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":55,"alternative-id":["S0753332222005261"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113137","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous and exogenous hydrogen sulfide modulates urothelial bladder carcinoma development in human cell lines","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113137"}}